The use of physical and chemical restraints in the pediatric emergency department

D H Dorfman1

  • 1Boston University School of Medicine/Boston Medical Center, Department of Pediatrics, Massachusetts 02118, USA. david.dorfman@bmc.org

Pediatric Emergency Care
|November 4, 2000
PubMed

Insights

Patient restraint is a dangerous last resort, requiring protocols and staff training to ensure safety. More research is needed on chemical and physical restraint methods, especially for children.

Area of Science:

  • Medical Ethics
  • Patient Safety
  • Clinical Practice

Background:

  • Patient restraint is a high-risk intervention.
  • Its use should be limited to situations where other methods have failed.
  • Inappropriate restraint poses risks to both patients and healthcare providers.

Purpose of the Study:

  • To emphasize the critical need for stringent protocols and comprehensive staff training.
  • To highlight the necessity of further clinical research into restraint methods.
  • To address the specific knowledge gaps concerning the restraint of pediatric patients.

Main Methods:

  • Review of current practices and ethical considerations surrounding patient restraint.
  • Analysis of the importance of established protocols and staff education.
  • Identification of areas requiring further clinical investigation.

Main Results:

  • Restraint should only be employed as a final option after all other de-escalation techniques are exhausted.
  • Well-defined protocols and thorough staff training are crucial for minimizing risks.
  • Significant gaps exist in the evidence base for chemical and physical restraint efficacy and safety, particularly in pediatric populations.

Conclusions:

  • Patient restraint necessitates a cautious, last-resort approach.
  • Robust protocols and staff training are paramount for safe application.
  • Further research is essential to optimize restraint strategies and ensure patient well-being, especially for children.

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...